 Connection
Emily Cole to Angiogenesis Inhibitors
This is a "connection" page, showing publications Emily Cole has written about Angiogenesis Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.174 |
|
|
|
-
Cole ED, Ferrara D, Novais EA, Louzada RN, Waheed NK. CLINICAL TRIAL ENDPOINTS FOR OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 2016 Dec; 36 Suppl 1:S83-S92.
Score: 0.118
-
Kniggendorf VF, Novais EA, Kniggendorf SL, Xavier C, Cole ED, Regatieri CV. Effect of intravitreal anti-VEGF on choroidal thickness in patients with diabetic macular edema using spectral domain OCT. Arq Bras Oftalmol. 2016 May-Jun; 79(3):155-8.
Score: 0.028
-
Novais EA, Adhi M, Moult EM, Louzada RN, Cole ED, Husvogt L, Lee B, Dang S, Regatieri CV, Witkin AJ, Baumal CR, Hornegger J, Jayaraman V, Fujimoto JG, Duker JS, Waheed NK. Choroidal Neovascularization Analyzed on Ultrahigh-Speed Swept-Source Optical Coherence Tomography Angiography Compared to Spectral-Domain Optical Coherence Tomography Angiography. Am J Ophthalmol. 2016 Apr; 164:80-8.
Score: 0.028
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|